Inhibition of hypoxia-induced phenotype alterations through epithelial-mesenchymal transition (EMT) in lung cancer by gene modulation of phosphorylation sites in tumor suppressor PTEN

N. Hashimoto, Y. Hasegawa (Nagoya, Japan)

Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Session: Lung cancer: molecular pathology and functional genomics
Session type: Poster Discussion
Number: 1949

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Hashimoto, Y. Hasegawa (Nagoya, Japan). Inhibition of hypoxia-induced phenotype alterations through epithelial-mesenchymal transition (EMT) in lung cancer by gene modulation of phosphorylation sites in tumor suppressor PTEN. Eur Respir J 2011; 38: Suppl. 55, 1949

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
GSK-3 inhibition suppresses lung cancer cell survival, metastasis and proliferation through down-regulation the phosphorylation sites of CAP1
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017

Suppression of HIF-1a dependent gene regulation by the tumour suppressor gene PTEN in pulmonary cells
Source: Eur Respir J 2001; 18: Suppl. 33, 17s
Year: 2001

The effect of compensatory induction of various PTEN mutants against TGFbeta-induced translocation of beta-catenin in lung cancer cells
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013

MicroRNA-101 inhibits lung cancer growth and invasion through regulation of EZH2
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010

Overexpression of LincR-PICALM promotes lung cancer proliferation and metastasis by miR-199a-3p suppression and cis- regulation
Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD
Year: 2019

EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020

Depletion of STAT6 suppresses lung cancer progression through regulating M2-macrophage polarization
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018

TGF-beta-induced transgelin 1 expression contributes to epithelial-to-mesenchymal transition in lung fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 604s
Year: 2006

Functional expressions of EGFP/LKB1 and its kinase domain induced apoptosis and enhanced chemosensitivity in lung cancer cell lines
Source: Eur Respir J 2004; 24: Suppl. 48, 5s
Year: 2004

Salinomycin suppresses TGF-ß1-induced EMT by down-regulating MMP-2,9 via AMPK-SIRT1 pathway in a non-small cell lung cancer
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017

Transcription factor FOXF1 induces cancer-associated fibroblast-like phenotype to promote lung cancer progression
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009



TGFβ induced myofibroblast differentiation is independent of p38 activation, but requires TGFβR1 kinase activity and correlates with TGFβ-mediated SMAD signaling and TGFβ-responsive gene expression patterns in human lung fibroblasts
Source: Eur Respir J 2004; 24: Suppl. 48, 718s
Year: 2004

Bile acid receptor accelerates to the lung cancer process induced by lung fibroblast-tumor cells interaction, with high activation of phosphorylated STAT3 and alteration of cytokine secretion
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017

Disruption of the HIF-1 pathway in cancer cells
Source: Research Seminar 2005 - Adaptations to Hypoxia
Year: 2005


Translocation of beta-catenin into cytoplasm during TGFbeta-induced EMT is negatively regulated by phosphorylation of the PTEN C-terminus in lung cancers
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013


Caspase recruitment domain containing protein 9 suppresses non-small cell lung cancer proliferation and invasion via inhibiting MAPK/p38 pathway
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020

Hypoxia-induced methylation of the Thy-1 promoter is associated with transcriptional repression in human primary lung fibroblasts
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010

PP221 – EZH2-dependent transcriptional complex promotes aberrant epithelial remodelling after injury
Source: ERS Lung Science Conference 2021
Year: 2021

Inhibition of insulin-like growth factor type I (IGF-I) gene in A549 human lung cancer cell line enhances cell apoptosis and causes phenotype changes relevant to increased tumor susceptibility to immune system
Source: Eur Respir J 2007; 30: Suppl. 51, 715s
Year: 2007

The mesenchymal gene, ADAM33, is not expressed during TGFβ-induced epithelial-mesenchymal transition (EMT) in lung epithelial cells
Source: Eur Respir J 2007; 30: Suppl. 51, 60s
Year: 2007